Queen's Anniversary Prize for university pharmacology department and institute of cancer research
The Queen’s Anniversary Prizes are awarded by the Royal Anniversary Trust and presented every two years to reward innovative work of outstanding quality within the higher and further education sector.
Pharmacologists at the University of Liverpool’s Department of molecular and clinical pharmacology have been awarded a in recognition of their work to improve the safety and effectiveness of medicines.
The prizes are awarded by the Royal Anniversary Trust and presented every two years to reward innovative work of outstanding quality within the higher and further education sector.
Twenty-one UK universities and colleges of further education have been awarded with a prize this year, which is the twelfth biennial round of the scheme.
The clinical pharmacology department in Liverpool is one of the oldest and largest in the UK, and is well known for its work in designing and creating novel drugs, running clinical trials on new drugs, and improving the use of existing drugs.
It also works to understand, predict and tackle adverse drug reactions, and it has developed tools that are used globally by physicians to avoid adverse drug reactions in susceptible patients delivering huge impact in the care of millions of patients.
Courtesy of David MacEwan
David MacEwan, head of the department said: “Through our bench to bedside approach, we continuously strive to ensure our work improves the development of medicines, for the benefit of society.
“It is a great honour to be awarded the Queen’s Anniversary Prize, which recognises the excellent work carried out by our staff.”
London’s Institute of Cancer Research (ICR) has also been recognised with a Queen’s Anniversary Prize for its role in pioneering the transition from one-size-fits-all chemotherapy to targeted drug treatment.
Since 2005, the ICR has discovered 20 new targeted cancer drugs and taken 9 into clinical trials.
Abiraterone, the innovative drug for advanced prostate cancer, discovered at the ICR, was approved for use on the NHS in 2012 and has extended the lives of hundreds of thousands of men around the world.
Citation: The Salvadore DOI: 10.1211/PJ.2017.20204059
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00
Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.£54.00
Case studies and MCQs explaining the pharmaceutics behind drug delivery.£33.00
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.£48.00
Remington Education: Drug Information & Literature Evaluation teaches students how to effectively and efficiently locate and analyze up-to-date drug information and literature.£27.00